21-Sep-2021 | Facts and Factors
As per a recently issued market research report by Facts & Factors, the global gene therapy market was about USD 2.7 Billion in 2020, with sales value projected to hit around USD 12.9 Billion by the end of 2026 and expected to register 22.3% CAGR during 2021 2026.
Gene therapy is the process of inoculation of a person’s genes for developing antibodies for treating and curating diseases. Gene therapy works by replacing a disease-causing gene with a healthy variation of the gene or by inactivating a disease-causing gene that does not have the proper functionality. The pivotal factors for the growth of the global gene therapy market are the rising prevalence of cancer and other targeted disorders coupled with increasing availability measures to name a few.
Additionally, including reimbursement packages among various insurance providers coupled with the rising funding for research and development measures will increase the footprint of the global gene therapy market during the forecast. Moreover, a dynamic competitive field created by the key market participants is further expected to fuel the growth of the global gene therapy market during the forecast period. A rising trend of life-threatening diseases such as heart diseases, AIDS, cystic fibrosis, and age-related disorders is expected to open new revenue opportunities for the global gene therapy market during the forecast duration.
Top Market Players
The key market participants for the gene therapy market are Bluebird Bio, Inc., TaxusCardium Pharmaceutical Group, Inc., UniQure N.V., Shire Plc, Cellectis S.A., Sangamo Therapeutics, Inc., Gilead Lifesciences, Inc., and Shanghai Sunway Biotech Co. Ltd., among others.
On the basis of vectors, the global gene therapy market can be broken down into viral and non-viral vectors. The segment pertaining to non-viral vectors is expected to witness the largest market share during the advent of the forecast owing to increasing technological advancements coupled with physicochemical approaches in lipid, naked DNA, chromosomes, plasmid, cationic polymers, and conjugate complexes to name a few.
On the basis of delivery mode, the global gene therapy market can be divided between in vivo and ex vivo. The ex vivo segment is expected to occupy the largest market share during the advent of the forecast owing to an easy mode of operation and easy deliverable method to name a few.
North America to Shine During the Advent of the Forecast in Terms of Global Revenue Contribution
North America is expected to witness the largest market share during the advent of the forecast owing to the increasing prevalence of chronic diseases coupled with a high and overlooking healthcare expenditure to name a few. Additionally, advanced healthcare facilities coupled with a steady state of reimbursement will increase the footprint of the gene therapy market in the region. Moreover, the rising number of key players in the region coupled with favorable regulatory approval will open new revenue opportunities for the gene therapy market in the region.
Browse in full “Gene Therapy Market By Vector (Viral & Non-Viral), By Delivery Mode (In Vivo & Ex Vivo), By Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026” report at https://www.fnfresearch.com/gene-therapy-market-by-type-germ-line-gene
The global gene therapy market can be segmented into:
Global Gene Therapy Market: By Vectors Segment Analysis
- Retroviral Vector
- Gammaretroviral Vector
- Lentiviral Vector
- Adeno-Associated Vector
- Other Viral Vectors
Global Gene Therapy Market: By Delivery Mode Segment Analysis
Global Gene Therapy Market: By Indication Segment Analysis
- Neurological Diseases
- Duchenne Muscular Dystrophy
- Hepatological Diseases
Global Gene Therapy Market: By Regional Segment Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Facts & Factors
A 2108, Sargam,
Pune 411041, India